Epidemiology and Risk Factors for Thromboembolic Complications of Childhood Nephrotic Syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) Study

Objectives To identify clinical variables predictive of the risk of thromboembolism (TE), and to confirm the incidence of TE in primary and secondary childhood nephrotic syndrome (NS). Study design A comprehensive chart review identified 326 children with NS from any cause evaluated between 1999 and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2009-07, Vol.155 (1), p.105-110.e1
Hauptverfasser: Kerlin, Bryce A., MD, Blatt, Neal B., MD, Fuh, Beng, MD, Zhao, Shuang, Lehman, Amy, PhD, Blanchong, Carol, MD, Mahan, John D., MD, Smoyer, William E., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To identify clinical variables predictive of the risk of thromboembolism (TE), and to confirm the incidence of TE in primary and secondary childhood nephrotic syndrome (NS). Study design A comprehensive chart review identified 326 children with NS from any cause evaluated between 1999 and 2006. These patients had a total of 1472.8 patient-years of follow-up. Comparison statistics, survival analysis, and logistic regression were used to define TE epidemiology and clinical risk factors. Results We found that 9.2% of our cohort had experienced at least 1 TE. The overall incidence was 20.4 patients with TEs/1000 patient-years. The median time to the first TE was 70.5 days after diagnosis of NS. Deep venous thrombosis was the most common TE (76%) and was frequently associated with the use of a central venous catheter (45%). Significant independent predictors of TE included age ≥ 12 years at onset of NS ( P < .0001), severity of proteinuria ( P < .0001), and history of TE preceding diagnosis of NS ( P < .0001). Life- or limb-threatening TEs represented 23.7% of the events. Conclusions Children with NS should be carefully followed for TE, particularly those who are age 12 years or older, have severe proteinuria, or have a previous history of TE.
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2009.01.070